MarketInOut Stock Screener Log In | Sign Up
 

Tectonic Therapeutic Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
Tectonic Therapeutic Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization400.76 mln
Float10.16 mln
Earnings Date11/05/2026

Piotroski F-Score

2 / 9
Weak

1-Year Forecast

71.00
Transformational upside

Relative Strength

19 / 100
Significantly lagging

Debt / Equity

0.02
Debt-free

ROE

-34.13
Deeply negative

ROA

-32.57
Deeply negative

Business Description

Tectonic Therapeutics is a biotechnology company based in Watertown, Massachusetts, focused on creating protein-based medicines that target a widely important class of receptors in the body known as GPCRs. The company has built a proprietary discovery platform that helps identify and develop these treatments more effectively. Its lead drug candidate is designed to activate a specific receptor involved in tissue repair and heart function, while additional programs are targeting serious conditions such as a rare blood vessel disorder and organ scarring.

Key Fundamentals

EPS-4.57
ROE-34.13
ROIC-1,044
ROA-32.57
Interest Cover-2,373
EBITDA, mln-82.68
EV / EBITDA-2.71
EV / EBIT-2.62

Quote Details

Last 20.07
Change -1.02 (-4.84%)
Open 21.03
Volume 144,968
Turnover 2,909,508
Average Volume 239,639

Financial Ratios

Leverage Ratio1.06
Current Ratio22.29
Price / Book2.00
Price / Tangible Book2.00
Debt / Equity0.02

Financial Strength

Piotroski F-Score 2 / 9
1-Year Target Price71.00
Short Ratio8.84
Short % of Float22.99

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -2.81% 23 / 100   
1 Month -16.79% 21 / 100   
2 Months -37.42% 13 / 100   
6 Months -29.68% 21 / 100   
1 Year 13.39% 71 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog